{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:09Z","timestamp":1786120329742,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1097\/mcg.0b013e31822a29c7","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T15:46:51Z","timestamp":1317743211000},"page":"321-323","source":"Crossref","is-referenced-by-count":4,"title":["Infliximab in Crohn's Disease-associated Toxic Megacolon"],"prefix":"10.1097","volume":"46","author":[{"given":"Erwin-Jan M.","family":"van Geenen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Sachar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210305","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1111\/j.1572-0241.2003.07696.x","article-title":"A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management.","volume":"98","author":"Gan","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R2-16-20210305","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0016-5085(19)33962-9","article-title":"An experience of ulcerative colitis I: toxic dilation in 55 cases.","volume":"57","author":"Jalan","year":"1969","journal-title":"Gastroenterology"},{"key":"R3-16-20210305","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(97)10475-5","article-title":"Toxic megacolon.","volume":"351","author":"Sheth","year":"1998","journal-title":"Lancet"},{"key":"R4-16-20210305","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1440-1746.2007.05079.x","article-title":"Epidemiology and clinical characteristics of ulcerative colitis in Chinese population: experience from a single center in Hong Kong.","volume":"23","author":"Lok","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"R5-16-20210305","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/BF02054220","article-title":"Severe Clostridium difficile colitis.","volume":"38","author":"Rubin","year":"1995","journal-title":"Dis Colon Rectum"},{"key":"R6-16-20210305","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00004836-198810000-00004","article-title":"Medical decompression of toxic megacolon by rolling: a new technique of decompression with favorable long-term follow-up.","volume":"10","author":"Present","year":"1988","journal-title":"J Clin Gastroenterol"},{"key":"R7-16-20210305","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1463-1318.2005.00887.x","article-title":"Aetiology and surgical management of toxic megacolon.","volume":"8","author":"Ausch","year":"2006","journal-title":"Colorectal Dis"},{"key":"R8-16-20210305","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00004836-199307000-00004","article-title":"Continuously infused cyclosporine at low dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids.","volume":"17","author":"Actis","year":"1993","journal-title":"J Clin Gastroenterol"},{"key":"R9-16-20210305","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy.","volume":"330","author":"Lichtiger","year":"1994","journal-title":"N Engl J Med"},{"key":"R10-16-20210305","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.cgh.2008.04.035","article-title":"Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis.","volume":"6","author":"Maser","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R11-16-20210305","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00384-002-0458-8","article-title":"Rescue therapy with tacrolimus in a patient with toxic megacolon.","volume":"18","author":"Pascu","year":"2003","journal-title":"Int J Colorectal Dis"},{"key":"R12-16-20210305","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(98)95043-7","article-title":"A new treatment for toxic megacolon.","volume":"352","author":"Kuroki","year":"1998","journal-title":"Lancet"},{"key":"R13-16-20210305","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10620-005-2571-3","article-title":"Leukocytapheresis (LCAP) for management of fulminant ulcerative colitis with toxic megacolon.","volume":"50","author":"Sawada","year":"2005","journal-title":"Dig Dis Sci"},{"key":"R14-16-20210305","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/gut.2009.192765","article-title":"Management of acute severe ulcerative colitis.","volume":"60","author":"Van Asche","year":"2011","journal-title":"Gut"},{"key":"R15-16-20210305","first-page":"426","article-title":"Severe ulcerative colitis, with toxic megacolon, resolved with infliximab therapy.","volume":"99","author":"Castro","year":"2007","journal-title":"Rev Esp Enferm Dig"},{"key":"R16-16-20210305","first-page":"259","article-title":"Effect of infliximab in the treatment of refractory inflammatory bowel disease with complication.","volume":"44","author":"Lee","year":"2004","journal-title":"Korean J Gastroenterol"},{"key":"R17-16-20210305","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/ibd.20139","article-title":"Fulminant Crohns colitis: when only an antibody will do.","volume":"13","author":"Ng","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R18-16-20210305","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0016-5085(80)90069-4","article-title":"Depth of ulceration in acute colitis: correlation with outcome and clinical and radiologic features.","volume":"79","author":"Buckell","year":"1980","journal-title":"Gastroenterology"},{"key":"R19-16-20210305","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00005792-196905000-00003","article-title":"Toxic dilatation of colon (toxic megacolon): etiology, treatment and prognosis in 42 patients.","volume":"48","author":"Norland","year":"1969","journal-title":"Medicine (Baltimore)"},{"key":"R20-16-20210305","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/0016-5085(95)90636-3","article-title":"Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon.","volume":"109","author":"Mourelle","year":"1995","journal-title":"Gastroenterology"},{"key":"R21-16-20210305","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0002-9610(86)90256-4","article-title":"Free colonic perforation without dilatation in ulcerative colitis.","volume":"152","author":"Greenstein","year":"1986","journal-title":"Am J Surg"},{"key":"R22-16-20210305","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00004836-198504000-00007","article-title":"Outcome of toxic dilatation in ulcerative and Crohns colitis.","volume":"7","author":"Greenstein","year":"1985","journal-title":"J Clin Gastroenterol"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004836-201204000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:22:31Z","timestamp":1786047751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004836-201204000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e31822a29c7","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}